Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2009 | 10-2008 | 07-2008 | 04-2008 | 01-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,042 | -6,370 | -10,653 | -7,394 | -5,287 |
| Depreciation Amortization | 1,522 | 754 | 2,146 | 1,387 | 910 |
| Income taxes - deferred | -184 | -105 | -644 | -370 | -276 |
| Accounts receivable | 871 | 664 | -2,837 | -2,822 | -1,203 |
| Accounts payable and accrued liabilities | -796 | -1,059 | -1,060 | -344 | -277 |
| Other Working Capital | 3,793 | 1,481 | -4,720 | -4,629 | -3,791 |
| Other Operating Activity | 4,672 | 3,170 | 9,204 | 7,187 | 4,215 |
| Operating Cash Flow | $-4,164 | $-1,465 | $-8,564 | $-6,985 | $-5,709 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -64,452 | -39,748 | N/A | N/A | N/A |
| PPE Investments | -1,558 | -829 | -3,231 | -1,596 | -1,019 |
| Net Acquisitions | N/A | N/A | -16,144 | -280 | -37 |
| Other Investing Activity | 165 | 342 | 594 | -216 | -240 |
| Investing Cash Flow | $-65,845 | $-40,235 | $-18,781 | $-2,092 | $-1,296 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 348 | 348 | 470 | 383 | 372 |
| Other Financing Activity | 0 | 0 | -12 | 0 | 0 |
| Financing Cash Flow | $348 | $348 | $458 | $383 | $372 |
| Exchange Rate Effect | -181 | -144 | 60 | 48 | 37 |
| Beginning Cash Position | 78,322 | 78,322 | 105,149 | 105,149 | 105,149 |
| End Cash Position | 8,480 | 36,826 | 78,322 | 96,503 | 98,553 |
| Net Cash Flow | $-69,842 | $-41,496 | $-26,827 | $-8,646 | $-6,596 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,164 | -1,465 | -8,564 | -6,985 | -5,709 |
| Capital Expenditure | -1,558 | -829 | -3,231 | -1,596 | -1,019 |
| Free Cash Flow | -5,722 | -2,294 | -11,795 | -8,581 | -6,728 |